Results 1 to 10 of about 31,760 (239)

Patient Harm Associated With Serial Phlebotomy and Blood Waste in the Intensive Care Unit: A Retrospective Cohort Study

open access: yesPLoS ONE, 2021
BackgroundIntensive care unit (ICU) patients are at high risk of anemia, and phlebotomy is a potentially modifiable source of blood loss. Our objective was to quantify daily phlebotomy volume for ICU patients, including blood discarded as waste during ...
Thomas Bodley   +2 more
exaly   +4 more sources

Clinical Applications of Therapeutic Phlebotomy

open access: yesJournal of Blood Medicine, 2016
Kyung Hee Kim,1 Ki Young Oh,2 1Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, 2Department of Physical Medicine and Rehabilitation, Soonchunhyang University, Cheonan Hospital, Cheonan, South Korea Abstract: Phlebotomy is
Kim KH, Oh KY
exaly   +4 more sources

Status of Phlebotomy Tube Utilization at a Major Medical Center. Are We Using Too Many Phlebotomy Tubes?

open access: yesHeliyon, 2023
Background and objectives: Overutilization of phlebotomy tubes at healthcare facilities leads to iatrogenic anemia, patient dissatisfaction, and increase in operational costs.
Xincen Duan, Wenqi Shao, Baishen Pan
exaly   +3 more sources

Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?

open access: yesEndocrine Connections
Erythrocytosis, or elevated hematocrit, is a common side effect of testosterone therapy (TTh) in male hypogonadism. Testosterone stimulates erythropoiesis through an initial rise in erythropoietin (EPO), the establishment of a new EPO/hemoglobin ‘set ...
Peter Bond   +2 more
doaj   +2 more sources

Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial

open access: yesJournal of Ovarian Research, 2019
Background Reduction of the body iron stores can improve hyperandrogenemia and insulin resistance. This study aimed to compare clinical and para-clinical responses to the treatment of phlebotomy using oral contraceptive pills (OCs) containing cyproterone
Samira Behboudi-Gandevani   +4 more
doaj   +2 more sources

Phlebotomy Staffing [PDF]

open access: yesArchives of Pathology & Laboratory Medicine, 2021
Context.— Laboratory directors are tasked with staffing laboratories in a manner that provides adequate services and maintains economic sustainability. Objective.— To determine the national normative rates of phlebotomy staffing and ...
David A, Novis   +4 more
openaire   +2 more sources

Iatrogenic blood loss in critical care: A prospective observational study conducted at Universitas Academic Hospital in the Free State Province, South Africa

open access: yesSouthern African Journal of Critical Care, 2022
Background. Prevention of iatrogenic blood loss is an essential component of patient blood management (PBM) in intensive care units (ICUs). The amount of iatrogenic blood loss from diagnostic phlebotomy in the ICUs at Universitas Academic Hospital, Free ...
J C Adams, C Barrett, M Spruyt
doaj   +1 more source

Hydralazine Associated With Reduced Therapeutic Phlebotomy Frequency in a Nationwide Cohort Study: Real-World Effectiveness for Drug Repurposing

open access: yesFrontiers in Pharmacology, 2022
Background: Therapeutic phlebotomy, known as scheduled bloodletting, has been the main method for managing erythrocytosis symptoms and thrombocytosis-associated complications in various blood disorders.
Wei-Zhi Lin   +11 more
doaj   +1 more source

Unexplained Hematocrit Increase after Therapeutic Phlebotomy in a Patient with Marked Erythrocytosis

open access: yesCase Reports in Hematology, 2022
We report a patient with hereditary erythrocytosis who underwent a therapeutic phlebotomy and had a post-phlebotomy hematocrit that was higher than the pre-phlebotomy hematocrit. We could not discern a reason for this hematocrit increase after phlebotomy.
Rushad Machhi   +5 more
doaj   +1 more source

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.

open access: yesThe Lancet Haematology, 2021
BACKGROUND There is no evidence that phlebotomy alone is sufficient to steadily maintain haematocrit on target level in low-risk patients with polycythaemia vera.
T. Barbui   +36 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy